The nation’s largest kidney dialysis company has set aside $495 million, including $45 million for legal fees and costs, to settle an Atlanta whistleblower case, according to a report the company made Monday to the U.S. Securities and Exchange Commission.

DaVita HealthCare Partners Inc. announced in the SEC filing that while the specific terms of the settlement are still being finalized, the company has accrued “an estimated loss contingency” of $495 million. DaVita’s intention to settle the eight-year-old litigation became public last month.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]